Bc. Paria et al., BLASTOCYSTS STATE OF ACTIVITY DETERMINES THE WINDOW OF IMPLANTATION IN THE RECEPTIVE MOUSE UTERUS, Proceedings of the National Academy of Sciences of the United Statesof America, 90(21), 1993, pp. 10159-10162
The present investigation studied the influence of the blastocyst's st
ate of activity on the ''window'' of implantation in the receptive ute
rus in the mouse. The receptive state of the uterus is defined as the
limited time when the uterine milieu is favorable to blastocyst accept
ance and implantation. In the mouse, implantation occurs on day 4 (day
1 = vaginal plug). Ovariectomy in the morning of day 4 prior to preim
plantation estrogen secretion results in blastocyst dormancy and delay
ed implantation. These conditions are maintained by continued progeste
rone (P4) treatment but can be terminated with an injection of estroge
n leading to blastocyst activation and subsequent implantation. Blasto
cyst transfers into intact pseudopregnant mice demonstrated that the w
indow of implantation on day 4 remains open at least through 1800 h fo
r normal day 4 blastocysts but only up to 1400 h for dormant blastocys
ts. These results suggested that the blastocyst's state of activity in
fluenced the normally operative window of implantation in the receptiv
e uterus. This finding was further confirmed by inducing conditions of
delayed implantation in pregnant donors and pseudopregnant recipients
. They were ovariectomized on the morning of day 4 and maintained with
daily injections of P4 from days 5 to 7. On day 7, dormant blastocyst
s from P4-treated delayed donors were transferred into the uteri of P4
-treated delayed pseudopregnant recipients at 1, 2, 4, or 8 h after an
injection of 17 beta-estradiol (E2). Dormant blastocysts transferred
into delayed recipients at 1 h after E2 treatment resulted in implanta
tion in most of the animals as compared to complete failure of blastoc
ysts to implant after transfer to P4-treated delayed recipients at 4 o
r 8 h after E2 treatment. However, implantation did occur in P4-treate
d delayed recipients at these later hours of E2 treatment when the P4-
treated delayed donors also received E2 prior to blastocyst transfer.
Furthermore, the majority of day 4 normal blastocysts implanted when t
ransferred into P4-treated delayed recipients even at 16 h after E2 tr
eatment. Interestingly, day 7 dormant blastocysts cultured for 8 or 24
h for in vitro activation failed to implant after transfer to P4-trea
ted delayed pseudopregnant recipients at 4 or 8 h after E2 treatment,
although they did implant after transfer at 1 h after E2 treatment. As
expected, normal day 4 blastocysts failed to implant after transfer t
o P4-treated delayed pseudopregnant recipients. Thus, these results es
tablish that the blastocyst's state of activity alters the timing of i
mplantation (window) in the receptive uterus. Thus, the window for suc
cessful implantation could be defined as a limited time span when the
activated stage of the blastocyst is superimposed on the receptive sta
te of the uterus. This window remains open for a shorter period for do
rmant blastocysts than for normal or dormant blastocysts after E2 acti
vation. Furthermore, dormant blastocysts, which apparently achieved me
tabolic activation in vitro, failed to attain the same status as blast
ocysts activated in utero by E2 for implantation into the receptive ut
erus. A key finding of this investigation is that E2 induces very rapi
dly, but transiently (1 h), a factor(s) in the P4-primed uterus that a
ctivates the dormant blastocysts for implantation in the receptive ute
rus.